| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $19.2M | $19.5M | $24.2M |
| YoY Revenue Growth % | -1.5% | -19.3% | — |
| Gross Profit | $12.0M | $12.0M | — |
| Gross Margin % | 62.4% | 61.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$2.2M | -$3.3M | -$22.5M |
| Operating Margin % | -11.3% | -17.0% | -80.0% |
| Net Income (GAAP) | -$2.0M | -$3.7M | -$22.9M |
| EBITDA (Normalized) | -$2.0M | -$3.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$1.5M | -$352.8K | -$4.3M |
| Capital Expenditures (CapEx) | $184.2K | $190.0K | — |
| Free Cash Flow (FCF) | -$1.6M | -$542.8K | -$4.3M |
| FCF Margin % | -8.5% | -2.8% | -17.8% |
| Return on Invested Capital (ROIC %) | -30.4% | -45.0% | — |
| Cash & Short-Term Equivalents | $3.4M | $2.0M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $9.0M | $1.8M | — |